Literature DB >> 15372622

Changes in receptor activator of nuclear factor-kappaB, and its ligand, osteoprotegerin, bone-type alkaline phosphatase, and tartrate-resistant acid phosphatase in ovariectomized rats.

Takashi Miyazaki1, Toshiyuki Matsunaga, Shuichi Miyazaki, Shigeru Hokari, Tsugikazu Komoda.   

Abstract

We investigated time-course changes in the expression of receptor activator of nuclear factor-kappaB (RANK), its ligand (RANKL), osteoprotegerin (OPG), bone-type alkaline phosphatase (BAP), and tartrate-resistant acid phosphatase (TRAP) in ovariectomized (OVX) rats. Samples of sera and coccyges were used for analysis of the enzyme activities and expression levels of proteins and mRNAs, and an immunohistochemical analysis was also performed. Serum BAP activity increased to 158.6% of the pre-operation value at 1 week after OVX, and then decreased to 38.7% at 8 weeks after OVX. On the other hand, the serum TRAP activity increased to 130.9% of the pre-operation level at 1 week after OVX, and was maintained at a high level, compared with the pre-operation level. The patterns of BAP and TRAP activity in the coccyges specimens were similar to those seen in the sera. The expression profiles of TRAP, RANK, and RANKL proteins in the coccyx specimens were similar to the pattern of serum TRAP activity, while the profiles of the BAP and OPG proteins were similar to the pattern of serum BAP activity in OVX rats. The changes in the mRNA expression levels of the osteogenic proteins were similar to those for protein expression. These biochemical changes in OVX rats were confirmed by immunohistochemical studies. Our results suggest that not only osteoclastogenesis accelerated but also osteoblastogenesis transiently increased during the early phase of osteoporosis. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15372622     DOI: 10.1002/jcb.20201

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  12 in total

1.  Marrow adipogenesis and bone loss that parallels estrogen deficiency is slowed by low-intensity mechanical signals.

Authors:  D Krishnamoorthy; D M Frechette; B J Adler; D E Green; M E Chan; C T Rubin
Journal:  Osteoporos Int       Date:  2015-09-01       Impact factor: 4.507

2.  L-Carnitine, but not coenzyme Q10, enhances the anti-osteoporotic effect of atorvastatin in ovariectomized rats.

Authors:  Hussam A S Murad
Journal:  J Zhejiang Univ Sci B       Date:  2016-01       Impact factor: 3.066

3.  Pulsed electromagnetic field stimulates osteoprotegerin and reduces RANKL expression in ovariectomized rats.

Authors:  Jun Zhou; Shiju Chen; Hua Guo; Lu Xia; Huifang Liu; Yuxi Qin; Chengqi He
Journal:  Rheumatol Int       Date:  2012-09-05       Impact factor: 2.631

Review 4.  Skeletal and extraskeletal actions of denosumab.

Authors:  Kathrin Sinningen; Elena Tsourdi; Martina Rauner; Tilman D Rachner; Christine Hamann; Lorenz C Hofbauer
Journal:  Endocrine       Date:  2012-05-13       Impact factor: 3.633

Review 5.  Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

Authors:  Ann E Kearns; Sundeep Khosla; Paul J Kostenuik
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

6.  Association between postmenopausal osteoporosis and experimental periodontitis.

Authors:  Kai Luo; Souzhi Ma; Jianbin Guo; Yongling Huang; Fuhua Yan; Yin Xiao
Journal:  Biomed Res Int       Date:  2014-02-10       Impact factor: 3.411

7.  The preventive effect of biochanin a on bone loss in ovariectomized rats: involvement in regulation of growth and activity of osteoblasts and osteoclasts.

Authors:  Shu-Jem Su; Yao-Tsung Yeh; Huey-Wen Shyu
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-21       Impact factor: 2.629

8.  Effects of the administration of corticosterone, parathyroid hormone, or both, and of their withdrawal, on rat bone and cartilage histomorphometric parameters, and on osteoprotegerin and RANKL mRNA expression and proteins.

Authors:  Giuliana Silvestrini; Paola Ballanti; Martina Leopizzi; Novella Gualtieri; Daniela Sardella; Paola Monnazzi; Simona Simeoni; Mariangela Sebastiani; Ermanno Bonucci; Francesca R Patacchioli
Journal:  J Mol Histol       Date:  2007-05-03       Impact factor: 3.156

9.  Comparison of dried plum supplementation and intermittent PTH in restoring bone in osteopenic orchidectomized rats.

Authors:  S Y Bu; E A Lucas; M Franklin; D Marlow; D J Brackett; E A Boldrin; L Devareddy; B H Arjmandi; B J Smith
Journal:  Osteoporos Int       Date:  2007-02-15       Impact factor: 5.071

10.  Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway.

Authors:  Zhiguang Chen; Jinqi Xue; Tao Shen; Shuai Mu; Qin Fu
Journal:  Int J Mol Med       Date:  2015-12-11       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.